Назад
Company hidden
8 дней назад

Director, Biostatistics (Clinical Development)

250 000 - 300 000$
Формат работы
hybrid
Тип работы
fulltime
Грейд
director
Английский
b2
Страна
US
Вакансия из списка Hirify.GlobalВакансия из Hirify Global, списка международных tech-компаний
Для мэтча и отклика нужен Plus

Мэтч & Сопровод

Для мэтча с этой вакансией нужен Plus

Описание вакансии

Текст:
/
TL;DR
Director, Biostatistics (Clinical Development): Providing strategic and operational statistical leadership across clinical development programs, including study activities, clinical team participation, and CRO oversight, with an accent on scientific rigor, regulatory compliance, and timely execution. Focus on leading biostatistical activities across multiple studies and applying hands-on statistical expertise to advance therapies for cardioendocrine diseases.

Location: South San Francisco, United States; on-site at least three days per week

Salary: $250,000–$300,000 per year

Company

hirify.global is a clinical-stage biotechnology company developing genetically validated therapies for serious cardioendocrine diseases.

What you will do

  • Provide strategic and operational biostatistical leadership across clinical development programs.
  • Lead statistical activities across multiple clinical studies.
  • Represent Biostatistics on clinical study teams.
  • Oversee external CRO partners and support timely execution.
  • Ensure scientific rigor and regulatory compliance across statistical activities.

Requirements

  • Experience leading biostatistical activities in clinical development.
  • Ability to combine hands-on statistical expertise with leadership responsibilities.
  • Ability to collaborate with clinical study teams and manage external CRO partners.
  • Availability to work in South San Francisco and on-site at least three days per week.

Culture & Benefits

  • Collaborative, hands-on working environment.
  • Opportunity to work across clinical programs addressing cardioendocrine diseases.
  • Direct contribution to the advancement of therapies approaching Phase 3 and Phase 2/3 development.

Будьте осторожны: если работодатель просит войти в их систему, используя iCloud/Google, прислать код/пароль, запустить код/ПО, не делайте этого - это мошенники. Обязательно жмите "Пожаловаться" или пишите в поддержку. Подробнее в гайде →